Heterogeneous Transcriptional Landscapes in Human Sporadic Parathyroid Gland Tumors

  • 0Laboratory of Experimental Biochemistry and Molecular Biology, IRCCS Ospedale Galeazzi-Sant'Ambrogio, 20157 Milan, Italy.

|

|

Summary

This summary is machine-generated.

Parathyroid adenomas (PAds) exhibit diverse gene expression patterns, influencing primary hyperparathyroidism (PHPT) severity. Specific lncRNAs and gene alterations correlate with distinct PAd subtypes and clinical outcomes.

Area Of Science

  • Endocrinology
  • Oncology
  • Molecular Biology

Background

  • Parathyroid tumors (adenomas) show molecular alterations impacting tumorigenesis.
  • Understanding these alterations is key to classifying parathyroid adenomas (PAds) and their clinical relevance.

Purpose Of The Study

  • To investigate the transcriptomic profiles of sporadic parathyroid adenomas (PAds).
  • To correlate gene and lncRNA expression patterns with clinical features of primary hyperparathyroidism (PHPT).

Main Methods

  • Gene, microRNA, and lncRNA expression profiling of 32 PAd samples.
  • Cluster analysis based on key tumorigenesis genes (e.g., MEN1, CDC73, CDKN1B).
  • Correlation of transcriptomic clusters with clinical and biochemical data.

Main Results

  • Two main transcriptomic clusters (C1, C2) identified, driven by CDC73 and CDKN1B expression.
  • Subcluster C2A showed loss of TP73 and increased lncRNAs, linked to more severe PHPT.
  • Subcluster C2B exhibited general gene downregulation, lower calcium/PTH, and smaller tumors.

Conclusions

  • PArathyroid adenomas display heterogeneous transcriptomic profiles.
  • These profiles correlate with clinical and biochemical variations in PHPT.
  • Downregulated gene expression in some PAds suggests quiescent tumor cells; p73 loss and lncRNA deregulation may drive PHPT severity.